Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Cell-free DNA sequencing in the clinical setting

Geoffrey Oxnard • 28 Sep 2019
ESMO 2019
General

Geoffrey Oxnard, MD, Dana-Farber Cancer Institute, Boston, MA, outlines how useful cell-free DNA sequencing will be in the clinical setting at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

More from Geoffrey Oxnard

3:41
Cell-free DNA for multi-cancer detection
Geoffrey Oxnard • 9 Apr 2020
2:54
Impact of COVID-19 on scientific research and treating patients
Geoffrey Oxnard • 9 Apr 2020
4:55
Cell-free DNA liquid biopsy in lung cancer
Geoffrey Oxnard • 9 Apr 2020
3:19
Cancer detecting and locating: cell-free DNA
Geoffrey Oxnard • 28 Sep 2019

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals